MX2015012733A - Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina. - Google Patents

Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina.

Info

Publication number
MX2015012733A
MX2015012733A MX2015012733A MX2015012733A MX2015012733A MX 2015012733 A MX2015012733 A MX 2015012733A MX 2015012733 A MX2015012733 A MX 2015012733A MX 2015012733 A MX2015012733 A MX 2015012733A MX 2015012733 A MX2015012733 A MX 2015012733A
Authority
MX
Mexico
Prior art keywords
methods
cell free
free dna
compositions
renal status
Prior art date
Application number
MX2015012733A
Other languages
English (en)
Inventor
Minnie M Sarwal
Tara Sigdel
Original Assignee
Immucor Gti Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immucor Gti Diagnostics Inc filed Critical Immucor Gti Diagnostics Inc
Publication of MX2015012733A publication Critical patent/MX2015012733A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La presente invención se refiere a herramientas no invasivas y métodos para evaluar el estado renal y la salud renal usando ADN libre de células de la orina.
MX2015012733A 2013-03-15 2014-03-15 Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina. MX2015012733A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361793427P 2013-03-15 2013-03-15
PCT/US2014/029956 WO2014145232A2 (en) 2013-03-15 2014-03-15 Methods and compositions for assessing renal status using urine cell free dna

Publications (1)

Publication Number Publication Date
MX2015012733A true MX2015012733A (es) 2016-06-21

Family

ID=51538435

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012733A MX2015012733A (es) 2013-03-15 2014-03-15 Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina.

Country Status (11)

Country Link
US (1) US20160024581A1 (es)
EP (1) EP2971135A4 (es)
JP (1) JP2016512698A (es)
KR (1) KR20160004265A (es)
CN (1) CN105102634A (es)
AU (1) AU2014233262A1 (es)
BR (1) BR112015022821A2 (es)
CA (1) CA2902006A1 (es)
HK (1) HK1217733A1 (es)
MX (1) MX2015012733A (es)
WO (1) WO2014145232A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
EP3957749A1 (en) 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
CN107072211B (zh) 2014-11-07 2020-09-22 巴斯夫欧洲公司 含有2-氧代-1,3-二氧戊环-4羧酸酯的农业化学助剂
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
WO2017020023A2 (en) * 2015-07-29 2017-02-02 Progenity, Inc. Nucleic acids and methods for detecting chromosomal abnormalities
EP3141612A1 (en) 2015-09-10 2017-03-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method and device for nucleic acid based diagnostic approaches including the determination of a deviant condtion, especially a health condition and/or pathogenic condition of a sample
CN109890977A (zh) * 2016-08-17 2019-06-14 加利福尼亚大学董事会 通过基于生物流体的无细胞dna(cfdna)测定评价器官损伤状态的基于免疫探针的新方法
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
WO2018099418A1 (en) * 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US20200109449A1 (en) * 2018-10-09 2020-04-09 Tai Diagnostics, Inc. Cell lysis assay for cell-free dna analysis
CN112424372A (zh) * 2019-01-24 2021-02-26 Illumina公司 用于监测器官健康和疾病的方法和系统
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
CN111833963A (zh) * 2019-05-07 2020-10-27 中国科学院北京基因组研究所 一种cfDNA分类方法、装置和用途
CN110452975A (zh) * 2019-06-28 2019-11-15 上海奥根诊断技术有限公司 用于检测ddcfDNA的产品在制备检测肺部感染引起的移植肾损伤和预后中的用途
CN112458162B (zh) * 2020-11-16 2023-04-18 北京迈基诺基因科技股份有限公司 器官移植ddcfDNA检测试剂和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198959A1 (en) * 2002-03-28 2003-10-23 Kurnit David M. Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
US7537889B2 (en) * 2003-09-30 2009-05-26 Life Genetics Lab, Llc. Assay for quantitation of human DNA using Alu elements
JP2010068800A (ja) * 2008-08-19 2010-04-02 Sumitomo Chemical Co Ltd Ｄｎａを定量又は検出する方法
US8574842B2 (en) * 2009-12-22 2013-11-05 The Board Of Trustees Of The Leland Stanford Junior University Direct molecular diagnosis of fetal aneuploidy
US9309565B2 (en) * 2010-05-14 2016-04-12 Life Technologies Corporation Karyotyping assay
AU2012249759A1 (en) * 2011-04-25 2013-11-07 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis

Also Published As

Publication number Publication date
CA2902006A1 (en) 2014-09-18
EP2971135A2 (en) 2016-01-20
BR112015022821A2 (pt) 2017-11-07
KR20160004265A (ko) 2016-01-12
CN105102634A (zh) 2015-11-25
US20160024581A1 (en) 2016-01-28
EP2971135A4 (en) 2016-11-09
JP2016512698A (ja) 2016-05-09
HK1217733A1 (zh) 2017-01-20
AU2014233262A1 (en) 2015-09-10
WO2014145232A2 (en) 2014-09-18
WO2014145232A3 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
MX2015012733A (es) Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina.
GB2535034A (en) Methods and systems for microbiome characterization, monitoring and treatment
HK1217971A1 (zh) 用於核酸分析的方法、組合物和試劑盒
HK1218934A1 (zh) 與端粒延伸相關的化合物、組合物、方法和試劑盒
HK1226939A1 (zh) 某些化學實體、組合物和方法
IL272171B (en) The compositions for the analysis of the interaction between RNA and chromatin, and their uses
GB2499921B (en) Biophotonic compositions, kits and methods
HK1224299A1 (zh) 用於關節健康之組合物及方法
PL2986735T3 (pl) Sposób określania składu ilościowego komórek krwi w próbce
EP2897618A4 (en) PARTICULAR CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
PT3272874T (pt) Composição de reagente para biossensor e biossensor tendo a mesma
EP2916838A4 (en) CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND CERTAIN PROCESSES
EP2806874A4 (en) Specific chemical substances, compositions and methods
EP2844773A4 (en) ANALYSIS OF BIOMARKERS USING SCODAPHORESIS
EP2852285A4 (en) CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
EP2959292A4 (en) METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG TRANSPLANTS
GB201317355D0 (en) Mutation Analysis
GB2512818B (en) Electrochemical reactions in flowing stream
EP2983497A4 (en) METHODS, COMPOSITIONS AND KITS FOR DETECTION OF PROTEASE ACTIVITY IN COMPLEX SAMPLES
EP2971114A4 (en) METHODS AND COMPOSITIONS FOR ASSESSING GENETIC MARKERS
EP2994541A4 (en) Diagnostic test for skeletal atavism in horses
AU341362S (en) Grill rake
GB201208203D0 (en) Online occupational health records
TH1401003726B (th) วิธีการและชุดเครื่องสำหรับประเมินกิจกรรมการใช้งานของผู้ใช้ในระบบทางสังคมแบบไม่ระบุชื่อ
GB201201295D0 (en) Compounds, compositions and methods for diagnosis